22 related articles for article (PubMed ID: 32014923)
1. Tumor growth-arrest effect of tetrahydroquinazoline-derivative human topoisomerase II-alpha inhibitor in HPV-negative head and neck squamous cell carcinoma.
Sarogni P; Brindani N; Zamborlin A; Gonnelli A; Menicagli M; Mapanao AK; Munafò F; De Vivo M; Voliani V
Sci Rep; 2024 Apr; 14(1):9150. PubMed ID: 38644364
[TBL] [Abstract][Full Text] [Related]
2. Impact of CD34-dependent Micro Vessel Density on Periapical Odontogenic Cysts.
Mathiou V; Tsiambas E; Maipas S; Thymara I; Peschos D; Lazaris AC; Kavantzas N
Cancer Diagn Progn; 2023; 3(2):189-193. PubMed ID: 36875307
[TBL] [Abstract][Full Text] [Related]
3. Expression of topoisomerase II alpha, Ki-67 and p53 in early stage laryngeal carcinomas not featuring vocal cord fixation.
Horibe Y; Murakami M; Komori K; Imaeda Y; Kasahara M
APMIS; 2000 Oct; 108(10):689-96. PubMed ID: 11200824
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase IIa protein expression analysis in oral squamous cell carcinoma.
Papanikolaou V; Kyrodimos E; Mastronikolis N; Tsiambas E; Ragos V; Chrysovergis A
J BUON; 2021; 26(3):769-773. PubMed ID: 34268934
[TBL] [Abstract][Full Text] [Related]
5. P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis.
Chrysovergis A; Papanikolaou V; Tsiambas E; Stavraka C; Ragos V; Peschos D; Psyrri A; Mastronikolis N; Kyrodimos E
Anticancer Res; 2019 Aug; 39(8):4137-4142. PubMed ID: 31366498
[TBL] [Abstract][Full Text] [Related]
6. Combined EGFR/ALK Expression Analysis in Laryngeal Squamous Cell Carcinoma.
Politi A; Tsiambas E; Mastronikolis NS; Peschos D; Asproudis I; Kyrodimos E; Armata IE; Chrysovergis A; Asimakopoulos A; Papanikolaou VS; Batistatou A; Ragos V
In Vivo; 2019; 33(3):815-819. PubMed ID: 31028202
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIalpha (TopoIIa) A New Promising Marker for Early Detection of Laryngeal Squamous Cell Carcinoma: An Immunohistochemical Study.
Salama MEM; Yaqout MAT; Habib FM; Abdel-Salam SM
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2135-2139. PubMed ID: 37378945
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma.
Papanikolaou V; Chrysovergis A; Mastronikolis N; Tsiambas E; Ragos V; Peschos D; Stavraka C; Roukas D; Kyrodimos E
Anticancer Res; 2020 Feb; 40(2):807-811. PubMed ID: 32014923
[TBL] [Abstract][Full Text] [Related]
9. The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma.
Wittekindt C; Wuerdemann N; Gattenlöhner S; Brobeil A; Wierzbicka M; Wagner S; Klußmann JP
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3837-3842. PubMed ID: 28861601
[TBL] [Abstract][Full Text] [Related]
10. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
